The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
According to WHO, pesticides are the leading cause of death by self-poisoning, particularly in low and middle income nations.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...